{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:14:32Z","timestamp":1783606472926,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018857","name":"International Myeloma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.leukres.2026.108254","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:01:38Z","timestamp":1779980498000},"page":"108254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determinants of clinical trial participation in multiple myeloma: A population-based cohort study from British Columbia"],"prefix":"10.1016","volume":"167","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Rouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Abou-Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cherniawsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0375-4858","authenticated-orcid":false,"given":"Shanee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Nantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujaatha","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nevill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-5664","authenticated-orcid":false,"given":"Afsaneh","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Bakharzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Piechnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-5801","authenticated-orcid":false,"given":"Claudie","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Stubbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Toze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-634X","authenticated-orcid":false,"given":"Julia","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P.","family":"Venner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kuchenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108254_bib1","unstructured":"Canadian Cancer Statistics Advisory Committee. Canadian cancer statistics 2021. Canadian Cancer Society, 2021."},{"issue":"14","key":"10.1016\/j.leukres.2026.108254_bib2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/cncr.32128","article-title":"Multiple myeloma epidemiology and patient geographic distribution in Canada: a population study","volume":"125","author":"Tsang","year":"2019","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.leukres.2026.108254_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25764","article-title":"Treatment and disease-related complications in multiple myeloma: implications for survivorship","volume":"95","author":"Chakraborty","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108254_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","volume":"21","author":"Murad","year":"2016","journal-title":"Evid. Based Med."},{"key":"10.1016\/j.leukres.2026.108254_bib5","unstructured":"National Institute on Aging. Clinical trials: benefits, risks, and safety: NIH; 2017 [cited 2023 May 16, 2023]. Available from: \u3008https:\/\/www.nia.nih.gov\/health\/clinical-trials-benefits-risks-and-safety\u3009."},{"issue":"10","key":"10.1016\/j.leukres.2026.108254_bib6","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","article-title":"Multiple myeloma: the (r)evolution of current therapy and a glance into future","volume":"105","author":"Gulla","year":"2020","journal-title":"Haematologica"},{"issue":"36","key":"10.1016\/j.leukres.2026.108254_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The role of clinical trial participation in cancer research: barriers, evidence, and strategies","author":"Unger","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"issue":"43","key":"10.1016\/j.leukres.2026.108254_bib8","article-title":"Equitable access to clinical trials: how do we achieve it?","volume":"8","author":"Acu\u00f1a-Villaordu\u00f1a","year":"2023","journal-title":"ASCO Educ. Book."},{"issue":"2","key":"10.1016\/j.leukres.2026.108254_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cct.2013.03.007","article-title":"A systematic review of the factors influencing African Americans' participation in cancer clinical trials","volume":"35","author":"Rivers","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.leukres.2026.108254_bib10","article-title":"Barriers for cancer clinical trial enrollment: a qualitative study of the perspectives of healthcare providers","volume":"28","author":"Kumar","year":"2022","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"11 Pt B","key":"10.1016\/j.leukres.2026.108254_bib11","first-page":"E575","article-title":"The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer","volume":"110","author":"Goyal","year":"2012","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.leukres.2026.108254_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10549-019-05276-y","article-title":"Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study","volume":"176","author":"Ohno","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"22","key":"10.1016\/j.leukres.2026.108254_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192215368","article-title":"Benefits of participation in clinical trials: an umbrella review","volume":"19","author":"Bouzalmate-Hajjaj","year":"2022","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"3","key":"10.1016\/j.leukres.2026.108254_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ejh.13899","article-title":"Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: a study based on the EORTC-Dutch late effects cohort-linked data","volume":"110","author":"Juul","year":"2023","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108254_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1471-0528.14528","article-title":"Participation in clinical trials improves outcomes in women's health: a systematic review and meta-analysis","volume":"124","author":"Nijjar","year":"2017","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.leukres.2026.108254_bib16","doi-asserted-by":"crossref","first-page":"dju002","DOI":"10.1093\/jnci\/dju002","article-title":"Comparison of survival outcomes among cancer patients treated in and out of clinical trials","volume":"106","author":"Unger","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.leukres.2026.108254_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jamcollsurg.2012.12.036","article-title":"Does enrollment in cancer trials improve survival?","volume":"216","author":"Chow","year":"2013","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.leukres.2026.108254_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-020-06916-z","article-title":"Are cancer patients better off if they participate in clinical trials? A mixed methods study","volume":"20","author":"Engelbak Nielsen","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2026.108254_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4732","article-title":"Comparison of clinical characteristics between clinical trial participants and nonparticipants using electronic health record data","volume":"4","author":"Rogers","year":"2021","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"10.1016\/j.leukres.2026.108254_bib20","first-page":"MR000009","article-title":"Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate","volume":"2008","author":"Vist","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7501","key":"10.1016\/j.leukres.2026.108254_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.330.7501.1175","article-title":"Systematic review to determine whether participation in a trial influences outcome","volume":"330","author":"Vist","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.leukres.2026.108254_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cllc.2021.04.003","article-title":"Impact of clinical trial participation on survival of patients with metastatic non-small cell lung cancer","volume":"22","author":"Merkhofer","year":"2021","journal-title":"Clin. Lung Cancer"},{"issue":"9405","key":"10.1016\/j.leukres.2026.108254_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)15383-4","article-title":"Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review","volume":"363","author":"Peppercorn","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.leukres.2026.108254_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22660","article-title":"Comparison of survival outcomes between clinical trial participants and non-participants of patients with advanced non-small cell lung cancer: a retrospective cohort study","volume":"9","author":"Jiang","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.leukres.2026.108254_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040590","article-title":"Socioeconomic factors and survival of multiple myeloma patients","volume":"13","author":"Chamoun","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.leukres.2026.108254_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12963-020-00244-x","article-title":"Comparisons of individual- and area-level socioeconomic status as proxies for individual-level measures: evidence from the mortality disparities in American communities study","volume":"19","author":"Moss","year":"2021","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.leukres.2026.108254_bib27","unstructured":"Statistics Canada. The Canadian index of multiple deprivation user guide [Webpage]. 2023 [updated October 22, 2024; cited 2024 December 15, 2024]. Available from: \u3008https:\/\/www150.statcan.gc.ca\/n1\/pub\/45-20-0001\/452000012023002-eng.htm\u3009."},{"issue":"4","key":"10.1016\/j.leukres.2026.108254_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/17407745221090733","article-title":"Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: a scoping review","volume":"19","author":"McPhee","year":"2022","journal-title":"Clin. Trials"},{"issue":"27","key":"10.1016\/j.leukres.2026.108254_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2026.108254_bib30","first-page":"78","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.leukres.2026.108254_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1743-7563.2010.01342.x","article-title":"Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients","volume":"7","author":"Sabesan","year":"2011","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108254_bib32","article-title":"Telehealth models could be extended to conducting clinical trials-a teletrial approach","volume":"27","author":"Sabesan","year":"2018","journal-title":"Eur J Cancer Care"},{"issue":"22","key":"10.1016\/j.leukres.2026.108254_bib33","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/cncr.34455","article-title":"Associations between geography, decision-making style, and interest in cancer clinical trial participation","volume":"128","author":"Caston","year":"2022","journal-title":"Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:22:02Z","timestamp":1783603322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0145212626000986"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108254","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of clinical trial participation in multiple myeloma: A population-based cohort study from British Columbia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108254"}}